Skip to main content

Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature

Abstract

Background

Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of lymphatic fluids into the intestinal lumen, causing depletion of lymphocytes, protein, lipids, fat-soluble vitamins, and electrolytes. Hypomagnesemia can occur in IL patients but is seldom discussed.

Case presentation

A 30-year-old Tibetan woman who had chronic diarrhea, edema, tetany, and tingling was diagnosed with IL. Prominent hypomagnesemia was noticed. She was treated with a medium-chain triglyceride (MCT) diet and nutrient supplementation with satisfactory results. We also present a systematic review of hypomagnesemia in IL cases from the published literature.

Conclusions

Hypomagnesemia may be an overlooked complication of IL, thus monitoring serum magnesium concentrations in IL patients is crucial.

Peer Review reports

Background

Intestinal lymphangiectasia (IL) is a rare disease with unknown prevalence and is characterized by dilated lymphatic vessels resulting in the leakage of lymphatic fluids into the intestinal lumen [1]. Primary IL has an early onset with undetermined etiology, whereas secondary IL is associated with preexisting conditions, including myxedema heart, systemic lupus erythematosus, radiotherapy/chemotherapy, Waldenstrom’s macroglobulinemia, primary peritoneal carcinoma, diffuse large B-cell lymphoma, and primary hypoparathyroidism [2]. Clinical presentations often include diarrhea/vomiting, edema, third cavity fluid accumulation, and recurrent infections. While hypoalbuminemia, hypogammaglobulinemia, lymphopenia, and hypocalcemia are well-known laboratory findings for IL, little is known about the magnesium levels in IL patients [1]. Absorption of magnesium in the small intestine plays an important part in its homeostasis, along with skeletal storage and renal excretion. In addition, one-third of the active form (as opposed to the storage form) of body magnesium is bound to albumin [3]. Thus, disturbed absorption and lowered albumin levels in IL patients may put these patients at a risk of magnesium depletion. Here, we present an intestinal lymphangiectasia case in which prominent hypomagnesemia was present and perform a systematic review of the published literature on this issue.

Case presentation

Anamnesis

A 30-year-old Tibetan woman was admitted for recurrent diarrhea, edema, tetany, and tingling for more than 10 years. Her symptoms first appeared when she was a teenager, and fatty meals caused diarrhea, edema of her face and extremities, and tingling. The symptoms were undiagnosed and lasted for two years before disappearing spontaneously. Three years ago, approximately 1 month after giving birth to her first baby, the same symptoms recurred. At first, her diarrhea was triggered by fatty meals, but gradually, she began to suffer from watery stool 3–6 times a day despite a fat-restricted diet. With worsening diarrhea, the patient gradually developed continuous facial and peripheral edema, a constant tingling sensation all over her body and tetany. Her past medical history revealed hepatitis B, total nephrectomy of her left kidney and subsequent chemotherapy and radiotherapy at the age of three due to a “kidney tumor”.

Clinical findings

The patient had a body mass index (BMI) of 19.5 kg/m2. On physical examination, she was otherwise normal except for a prominent forehead, peripheral pitting edema and abdominal shifting dullness. Laboratory examination revealed lymphopenia, hypoalbuminemia, hypogammaglobulinemia, hypokalemia, hypocalcemia, hypophosphatemia, and hypomagnesemia (Table 1). The high-sensitivity C-reactive protein (hsCRP) level and erythrocyte sedimentation rate (ESR) were within normal limits. Screening of fat-soluble vitamins showed decreased serum vitamin A, vitamin D and vitamin E at the lower limit. Routine urine and stool analyses were normal. Electrocardiogram (ECG) showed a prolonged QT interval at 445 ms.

Table 1 Laboratory findings for the patient

Diagnostic focus and assessment

The marked hypoalbuminemia account for her edema, and the hypocalcemia account for her tetany and tingling. The diarrhea seemed to be the culprit of the hypoalbuminemia since there was no evidence of liver synthesis dysfunction or renal protein leakage. Protein-losing gastroenteropathy was suspected, and the common etiologies of protein-losing gastroenteropathy may include inflammatory bowel disease, infection and IL. While normal hsCRP, ESR and stool analysis made the former two differential diagnoses unlikely, lymphatic imaging using a 99m technetium-labeled tracer showed lymph leakage into the intestines. Endoscopically, there were whitish granules in the descending duodenum and the terminal ileum (Fig. 1), which were later proven to be dilated lymphatic vessels by pathology evaluation. IL secondary to heart dysfunction, portal vein hypertension or malignancy obstruction was ruled out by normal findings on echocardiogram and thoracic/abdominal/pelvic computed tomography scanning, respectively. The patient was eventually diagnosed with IL, which was probably secondary to radiotherapy/chemotherapy of the retroperitoneal region. Her IL was complicated by nutrient deficiencies, including hypomagnesemia.

Fig. 1
figure 1

Whitish granules in the 2nd part of the duodenum seen by endoscopy

Therapeutic focus and outcome

A strict MCT diet was given, and her diarrhea and edema gradually improved, with serum albumin rising to 25 g/L. Oral calcium, calcitriol, potassium supplements were given, as well as intravenous sodium glycerophosphate, which restored serum calcium to 1.98 mmol/L (2.28 after correction for albumin level), potassium to 4.1 mmol/L, and phosphorus to 0.57 mmol/L (Fig. 2). The tetany and tingling all disappeared. For her hypomagnesemia, intravenous magnesium sulfate was given for 3 days before the serum magnesium level rose to 0.45 mmol/L, followed by oral magnesium sulfate for another 3 days, which brought her magnesium level to 0.74 mmol/L before discharge.

Fig. 2
figure 2

Treatment and changes in electrolytes. A medium chain triglyceride diet and mineral supplements were given to restore the electrolyte balance. Potassium chloride, calcium carbonate, and calcitriol were given from Day 0, and a medium chain triglyceride diet, intravenous magnesium sulfate, and intravenous sodium glycerophosphate were given from Day 3. From Day 6, magnesium sulfate was given orally. The electrolyte status gradually improved. KCl, potassium chloride; CaCO3, calcium carbonate; MgSO4, magnesium sulfate; MCT, medium chain triglyceride; g, gram; IV, intravenous drip; po, orally; qd, once daily; tid, three times a day

Discussion and conclusion

Depletion of multiple materials in the blood is expected with excessive loss of the nutrient-rich lymph in IL patients. Lymphopenia, hypoalbuminemia, and hypogammaglobulinemia are common laboratory findings in IL. Iron, calcium, lipids, and fat-soluble vitamins may also be depleted. We believe this case of hypomagnesemia in a patient with IL is unique because few IL reports provide information on serum magnesium levels, and even fewer address the treatment of hypomagnesemia.

The prominent hypomagnesemia in our case alerted us to investigate the literature on this issue. Out of the 274 PubMed database retrievable IL cases where biochemical laboratory results were provided, only 23 cases (8%) reported the serum magnesium concentration (Table 2) [2, 4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23].

Table 2 Summary of published IL cases with serum magnesium concentration results

The mechanism by which hypomagnesemia occurs in IL could be manifold. Diarrhea, which occurs in almost every IL case with hypomagnesemia, could result in inadequate magnesium absorption. Since one-third of serum magnesium is bound to albumin, hypoalbuminemia may also disrupt magnesium transportation and balance [24]. Multiple linear regression analyses of the data from Table 2 showed that there were no correlations between serum magnesium levels and total calcium, corrected calcium, or albumin levels (P = 0.2620, P = 0.6311, P = 0.8885, respectively; GraphPad Prism 8, San Diego, USA). Albumin levels do not affect serum magnesium levels. However, due to the small sample size, this conclusion should be interpreted with caution. The Tibetan patient’s diet lacked green leafy vegetables, which are a good source of magnesium, and might have also contributed to the hypomagnesemia in our case.

There could be several potential clinical consequences of hypomagnesemia in IL patients. Severely lowered serum magnesium can cause arrhythmias, including PR interval prolongation, progressive QRS widening, and, most notably, torsades de pointes. Additionally, hypomagnesemia can give rise to neuromuscular hyperactivity, causing tetany and seizures. Hypomagnesemic tetany was reported in one IL patient [20]. Hypokalemia and hypocalcemia are common findings in IL patients. Since magnesium plays a regulatory role in potassium and calcium metabolism, hypomagnesemia could have further complicated these two electrolyte disturbances. In one case, hypocalcemia was recalcitrant to vitamin D and calcium supplementation and was only corrected by magnesium injections [23].

The treatment for hypomagnesemia in IL patients should be individualized. For severe hypomagnesemia with symptoms, intravenous magnesium sulfate is the preferred option. Days may be needed for the restoration of normal concentrations because as much as 50% of the injected magnesium would be lost from the urine. For moderate to mild asymptomatic situations, oral replacement might be adequate [3]. The serum level should be closely monitored, especially in patients with impaired renal function, for whom the risk of hypermagnesemia is high.

In conclusion, hypomagnesemia may be an overlooked complication of IL, and the monitoring of serum magnesium concentration is essential, especially in patients with concomitant neuromuscular and ionic abnormalities, as well as a magnesium-deficient dietary habit.

Availability of data and materials

All relevant data can be found in the text of this article and the references.

Abbreviations

IL:

Intestinal lymphangiectasia

MCT:

Medium chain triglyceride

g:

Gram

L:

Liter

cm:

Centimeter

BMI:

Body mass index

kg:

Kilogram

m:

Meter

ECG:

Electrocardiogram

hsCRP:

High-sensitivity C-reactive protein

ESR:

Erythrocyte sedimentation rate

References

  1. Huber R, Semmler G, Mayr A, Offner F, Datz C. Primary intestinal lymphangiectasia in an adult patient: a case report and review of literature. World J Gastroenterol. 2020;26(48):7707–18.

    Article  Google Scholar 

  2. Alshikho MJ, Talas JM, Noureldine SI, Zazou S, Addas A, Kurabi H, et al. Intestinal lymphangiectasia: insights on management and literature review. Am J Case Rep. 2016;17:512–22.

    Article  Google Scholar 

  3. Ahmed F, Mohammed A. Magnesium: the forgotten electrolyte—a review on hypomagnesemia. Med Sci. 2019;7(4):56.

    Google Scholar 

  4. Altın Z, Atabay Y, Özer S, Karakoyun M, Ekmekçi S, Yürekli EY, et al. Primary intestinal lymphangiectasia and a review of the current literature. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2018;29(6):714–6.

    Article  Google Scholar 

  5. Lu J, Zhai H. Exacerbation of primary intestinal lymphangiectasia during late pregnancy and recovery after delivery: a case report and literature review. Medicine. 2017;96(35):e7928.

    Article  Google Scholar 

  6. O’Donnell D, Myers AM. Intestinal lymphangiectasia with protein losing enteropathy, toxic copper accumulation and hypoparathyroidism. Aust N Z J Med. 1990;20(2):167–9.

    Article  Google Scholar 

  7. Orbeck H, Larsen TE, Hovig T. Transient intestinal lymphangiectasia. Acta Paediatr Scand. 1978;67(5):677–82.

    CAS  Article  Google Scholar 

  8. Ozeki M, Hori T, Kanda K, Kawamoto N, Ibuka T, Miyazaki T, et al. Everolimus for primary intestinal lymphangiectasia with protein-losing enteropathy. Pediatrics. 2016;137(3):e20152562.

    Article  Google Scholar 

  9. Troskot R, Jurčić D, Bilić A, Gomerčić Palčić M, Težak S, Brajković I. How to treat an extensive form of primary intestinal lymphangiectasia? World J Gastroenterol. 2015;21(23):7320–5.

    Article  Google Scholar 

  10. Licinio R, Principi M, Ierardi E, Leo AD. Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic. World J Hepatol. 2014;6(9):685–7.

    Article  Google Scholar 

  11. Klingenberg RD, Homann N, Ludwig D. Type I intestinal lymphangiectasia treated successfully with slow-release octreotide. Dig Dis Sci. 2003;48(8):1506–9.

    CAS  Article  Google Scholar 

  12. Gumà J, Rubió J, Masip C, Alvaro T, Borràs JL. Aggressive bowel lymphoma in a patient with intestinal lymphangiectasia and widespread viral warts. Ann Oncol Off J Eur Soc Med Oncol. 1998;9(12):1355–6.

    Article  Google Scholar 

  13. Lu Y-Y, Wu J-F, Ni Y-H, Peng SS-F, Chia-Tung S, Chang M-H. Hypocalcemia and tetany caused by vitamin D deficiency in a child with intestinal lymphangiectasia. J Formos Med Assoc. 2009;108(10):814–8.

    Article  Google Scholar 

  14. Koçak G, Koçak E, Akbal E, Duranay M, Köklü S. A rare cause of severe hypoalbuminemia in a patient with primary hypoparathyroidism: intestinal lymphangiectasia. Acta Clin Belg. 2011;66(3):246.

    PubMed  Google Scholar 

  15. Hennekam RC, Geerdink RA, Hamel BC, Hennekam FA, Kraus P, Rammeloo JA, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34(4):593–600.

    CAS  Article  Google Scholar 

  16. Köstel-Bal AS, Kaymak S, Haskoloğlu Ş, Kuloğlu Z, Ensari A, Doğu F, et al. A clinical approach to a child with hypoalbuminemia and lymphopenia. J Clin Immunol. 2016;36(4):370–3.

    Article  Google Scholar 

  17. Van Biervliet S, Velde SV, Robberecht E, Van Winckel M. Hypocalcaemic seizures: sign of intestinal disease? Acta Gastro-Enterol Belg. 2007;70(2):243–4.

    Google Scholar 

  18. Huppke P, Christen HJ, Sattler B, Hanefeld F. Two brothers with Hennekam syndrome and cerebral abnormalities. Clin Dysmorphol. 2000;9(1):21–4.

    CAS  Article  Google Scholar 

  19. Hamada A, Kondoh T, Kamei T, Tominaga N, Tsuru A, Matsumoto T, et al. Protein-losing enteropathy complicated with recurrent convulsions and developmental delay in a 4-month-old boy. Pediatr Int Off J Jpn Pediatr Soc. 2002;44(6):686–9.

    Article  Google Scholar 

  20. Zimmet P, Breidahl HD. Intestinal lymphangiectasia with hypomagnesaemic tetany. Australas Ann Med. 1968;17(3):265–9.

    CAS  Article  Google Scholar 

  21. Eisner JW, Bralow SP. Intestinal lymphangiectasia with immunoglobulin A deficiency. Am J Dig Dis. 1968;13(12):1055–64.

    CAS  Article  Google Scholar 

  22. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1984. An elderly woman with protein-losing enteropathy and pleural effusions. N Engl J Med. 1984;310(8):512–20.

    Article  Google Scholar 

  23. Bereket A, Lowenheim M, Blethen SL, Kane P, Wilson TA. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. J Clin Endocrinol Metab. 1995;80(3):933–5.

    CAS  PubMed  Google Scholar 

  24. Liu M, Yang H, Mao Y. Magnesium and liver disease. Ann Transl Med. 2019;7(20):578.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Beijing Science and Technology Program (Z181100001618013); Peking Union Medical College Education Reform Program (2019zlgc0116).

Author information

Authors and Affiliations

Authors

Contributions

HF and LZ contributed to the design and drafting of the case report; HF, LZ, and SZ contributed to the reviewing of the literature; JL, SZ, XZ, and HF made the diagnosis and treatment plan for the patient; SZ, JL, and XZ provided critical revision of the article. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shengyu Zhang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written consent was obtained from the patient for the personal and clinical details along with any identifying images to be published in this study.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Feng, H., Zou, L., Zhai, X. et al. Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature. BMC Gastroenterol 22, 246 (2022). https://doi.org/10.1186/s12876-022-02318-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12876-022-02318-6

Keywords

  • Intestinal lymphangiectasia
  • Waldmann’s disease
  • Protein-losing enteropathy
  • Hypoproteinemia
  • Case report